BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 10762631)

  • 1. p21 is associated with cyclin D1, p16INK4a and pRb expression in resectable non-small cell lung cancer.
    Vonlanthen S; Heighway J; Kappeler A; Altermatt HJ; Borner MM; Betticher DC
    Int J Oncol; 2000 May; 16(5):951-7. PubMed ID: 10762631
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alterations of cell cycle regulators are less frequent in advanced non-small cell lung cancer than in resectable tumours.
    Gugger M; Kappeler A; Vonlanthen S; Altermatt HJ; Ris HB; Lardinois D; Borner MM; Heighway J; Betticher DC
    Lung Cancer; 2001; 33(2-3):229-39. PubMed ID: 11551418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of p16INK4a/p16alpha and p19ARF/p16beta is frequently altered in non-small cell lung cancer and correlates with p53 overexpression.
    Vonlanthen S; Heighway J; Tschan MP; Borner MM; Altermatt HJ; Kappeler A; Tobler A; Fey MF; Thatcher N; Yarbrough WG; Betticher DC
    Oncogene; 1998 Nov; 17(21):2779-85. PubMed ID: 9840942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms of G1 checkpoint loss in resected early stage non-small cell lung cancer.
    Zhou JX; Niehans GA; Shar A; Rubins JB; Frizelle SP; Kratzke RA
    Lung Cancer; 2001 Apr; 32(1):27-38. PubMed ID: 11282426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic significance of p21waf1, cyclin D1 and retinoblastoma expression detected by immunohistochemistry in non-small cell lung cancer.
    Saitoh G; Sugio K; Ishida T; Sugimachi K
    Oncol Rep; 2001; 8(4):737-43. PubMed ID: 11410775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction of retinoblastoma protein and D cyclins during cell-growth inhibition by hexamethylenebisacetamide in TM2H mouse epithelial cells.
    Said TK; Medina D
    Mol Carcinog; 1998 Jun; 22(2):128-43. PubMed ID: 9655257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. P16Ink4a tumor suppressor function in lung cancer cells involves cyclin-dependent kinase 2 inhibition by Cip/Kip protein redistribution.
    Grimison B; Langan TA; Sclafani RA
    Cell Growth Differ; 2000 Oct; 11(10):507-15. PubMed ID: 11063124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. G1 control gene status is frequently altered in resectable non-small cell lung cancer.
    Betticher DC; White GR; Vonlanthen S; Liu X; Kappeler A; Altermatt HJ; Thatcher N; Heighway J
    Int J Cancer; 1997 Oct; 74(5):556-62. PubMed ID: 9355981
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21waf1/cip1, p27kip1 in colorectal carcinoma: correlation with other cell cycle regulators (pRb, p53 and Ki-67 and PCNA) and clinicopathological features.
    Ioachim E
    Int J Clin Pract; 2008 Nov; 62(11):1736-43. PubMed ID: 19143860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic implications of cell cycle-related proteins in primary resectable pathologic N2 nonsmall cell lung cancer.
    Mohamed S; Yasufuku K; Hiroshima K; Nakajima T; Yoshida S; Suzuki M; Sekine Y; Shibuya K; Iizasa T; Farouk A; Fujisawa T
    Cancer; 2007 Jun; 109(12):2506-14. PubMed ID: 17487846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. G1 arrest of U937 cells by onconase is associated with suppression of cyclin D3 expression, induction of p16INK4A, p21WAF1/CIP1 and p27KIP and decreased pRb phosphorylation.
    Juan G; Ardelt B; Li X; Mikulski SM; Shogen K; Ardelt W; Mittelman A; Darzynkiewicz Z
    Leukemia; 1998 Aug; 12(8):1241-8. PubMed ID: 9697879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic implications of molecular and immunohistochemical profiles of the Rb and p53 cell cycle regulatory pathways in primary non-small cell lung carcinoma.
    Burke L; Flieder DB; Guinee DG; Brambilla E; Freedman AN; Bennett WP; Jones RT; Borkowski A; Caporaso NA; Fleming M; Trastek V; Pairolero P; Tazelaar H; Midthun D; Jett JR; Liotta LA; Travis WD; Harris CC
    Clin Cancer Res; 2005 Jan; 11(1):232-41. PubMed ID: 15671551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21(Waf1/Cip1) and p27(Kip1) in urothelial carcinoma: correlation with other cell-cycle-related proteins (Rb, p53, Ki-67 and PCNA) and clinicopathological features.
    Ioachim E; Michael M; Stavropoulos NE; Kitsiou E; Hastazeris K; Salmas M; Stefanaki S; Agnantis NJ
    Urol Int; 2004; 73(1):65-73. PubMed ID: 15263796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Direct interaction of p21 cyclin-dependent kinase inhibitor with the retinoblastoma tumor suppressor protein.
    Nakanishi M; Kaneko Y; Matsushime H; Ikeda K
    Biochem Biophys Res Commun; 1999 Sep; 263(1):35-40. PubMed ID: 10486249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rb and p16INK4a expression in resected non-small cell lung tumors.
    Kratzke RA; Greatens TM; Rubins JB; Maddaus MA; Niewoehner DE; Niehans GA; Geradts J
    Cancer Res; 1996 Aug; 56(15):3415-20. PubMed ID: 8758904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in expression of pRb, p16 and cyclin D1 in non-small cell lung cancer: an immunohistochemical study.
    Malusecka E; Zborek A; Krzyzowska-Gruca S
    Folia Histochem Cytobiol; 1999; 37(1):19-24. PubMed ID: 10091946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of p16 and lack of pRB in primary small cell lung cancer.
    Yuan J; Knorr J; Altmannsberger M; Goeckenjan G; Ahr A; Scharl A; Strebhardt K
    J Pathol; 1999 Nov; 189(3):358-62. PubMed ID: 10547597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Replicative senescence in human uroepithelial cells.
    Puthenveettil JA; Burger MS; Reznikoff CA
    Adv Exp Med Biol; 1999; 462():83-91. PubMed ID: 10599415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of cyclin-dependent kinase 4 during adipogenesis involves switching of cyclin D subunits and concurrent binding of p18INK4c and p27Kip1.
    Phelps DE; Xiong Y
    Cell Growth Differ; 1998 Aug; 9(8):595-610. PubMed ID: 9716177
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value of cyclin D1 overexpression in correlation with pRb and p53 status in non-small cell lung cancer (NSCLC).
    Dworakowska D; Jassem E; Jassem J; Boltze C; Wiedorn KH; Dworakowski R; Skokowski J; Jaƛkiewicz K; Czestochowska E
    J Cancer Res Clin Oncol; 2005 Jul; 131(7):479-85. PubMed ID: 15809880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.